Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Amrubicin |
Synonyms | |
Therapy Description |
Amrubicin is a synthetic anthracycline, which intercalates into DNA resulting in growth inhibition and cell death (PMID: 21188110). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Amrubicin | Chemotherapy - Anthracycline 11 | Amrubicin is a synthetic anthracycline, which intercalates into DNA resulting in growth inhibition and cell death (PMID: 21188110, PMID: 32569168). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02481830 | Phase III | Amrubicin Nivolumab Topotecan | Efficacy Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer | Active, not recruiting | USA | ITA | FRA | ESP | DEU | BEL | AUT | 18 |